Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy for Critically-Ill COVID-19 Patients

NCT04457609 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.

NCT NCT04457609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04457609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy for Critically-Ill COVID-19 Patients
Lead sponsor
Indonesia University
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2020
Completion date
September 30, 2020
Enrollment
40 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid, pulmonary infection, sars-cov2